Intranasal bilosomes in thermosensitive hydrogel: advancing desvenlafaxine succinate delivery for depression management.

Autor: El-Nawawy TM; Department of Pharmaceutics, Egyptian Drug Authority (EDA), Cairo, Egypt., Adel YA; Department of Pharmaceutics, Egyptian Drug Authority (EDA), Cairo, Egypt., Teaima M; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt., Nassar NN; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.; Department of Pharmacology and Toxicology, Faculty of Pharmacy, October University for Modern Science and Arts (MSA), Giza, Egypt., Nemr AA; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt., Al-Samadi I; Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza., El-Nabarawi MA; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt., Elhabal SF; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Egypt.

Publikováno v: Pharmaceutical development and technology [Pharm Dev Technol] 2024 Sep; Vol. 29 (7), pp. 663-674. Date of Electronic Publication: 2024 Jul 15.

PET/CT study of dopamine transporter (DAT) binding with the triple reuptake inhibitor toludesvenlafaxine in rats and humans.

Autor: Huang Z; Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Wu J; Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China., Guan Y; Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China., Wei Y; Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Xie F; Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China. Fangxie@fudan.edu.cn., Shen Y; Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. shenyifeng@yahoo.com.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jul; Vol. 51 (9), pp. 2638-2648. Date of Electronic Publication: 2024 Apr 08.

Compritol ^® -based solid lipid nanoparticles of desvenlafaxine prepared by ultrasonication-assisted hot-melt encapsulation to modify its release.

Autor: Rao H; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Punjab, 63100, Pakistan., Rao I; King Edward Medical University Lahore, Lahore, Punjab, Pakistan., Ahmad S; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Punjab, 63100, Pakistan., Madni A; Department of Pharmaceutics, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Punjab, 63100, Pakistan., Ahmad I; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Punjab, 63100, Pakistan.

Publikováno v: Nanomedicine (London, England) [Nanomedicine (Lond)] 2024; Vol. 19 (11), pp. 965-978. Date of Electronic Publication: 2024 Apr 09.

Multiplexed quantification of venlafaxine and metabolites in human plasma by liquid chromatography-tandem mass spectrometry.

Autor: Pandey A; Department of Medicine, Johns Hopkins University, Bayview Medical Center, 4940 Eastern Ave, Mason F. Lord Tower, Suite 6000, Room 607, Baltimore, MD 21224, USA., Price A; Department of Medicine, Johns Hopkins University, Bayview Medical Center, 4940 Eastern Ave, Mason F. Lord Tower, Suite 6000, Room 607, Baltimore, MD 21224, USA., Ayala-Lopez N; Department of Pathology, Johns Hopkins University, 1800 Orleans St., Sheikh Zayed Tower, B1020-G, Baltimore, MD 21287, USA., Garza KY; Department of Pathology, Johns Hopkins University, 1800 Orleans St., Sheikh Zayed Tower, B1020-G, Baltimore, MD 21287, USA., Marzinke MA; Department of Medicine, Johns Hopkins University, Bayview Medical Center, 4940 Eastern Ave, Mason F. Lord Tower, Suite 6000, Room 607, Baltimore, MD 21224, USA; Department of Pathology, Johns Hopkins University, 1800 Orleans St., Sheikh Zayed Tower, B1020-G, Baltimore, MD 21287, USA., Knezevic CE; Department of Pathology, Johns Hopkins University, 1800 Orleans St., Sheikh Zayed Tower, B1020-G, Baltimore, MD 21287, USA. Electronic address: cknezev1@jhmi.edu.

Publikováno v: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 Jun 15; Vol. 243, pp. 116082. Date of Electronic Publication: 2024 Mar 07.

CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression.

Autor: Men X; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada., Taylor ZL; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Marshe VS; Department of Neurology, Columbia University Irving Medical Center, New York, New York, USA., Blumberger DM; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada., Karp JF; Department of Psychiatry, The University of Arizona College of Medicine, Tucson, Arizona, USA., Kennedy JL; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada., Lenze EJ; Department of Psychiatry, Washington University, St. Louis, Missouri, USA., Reynolds CF 3rd; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Stefan C; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Clinical Laboratory and Diagnostic Services, Centre for Addiction and Mental Health, Toronto, Ontario, Canada., Mulsant BH; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada., Ramsey LB; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Division of Research in Patient Services, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Müller DJ; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 May; Vol. 115 (5), pp. 1065-1074. Date of Electronic Publication: 2024 Jan 29.